Efficient syntheses of new heteroarotinoids through functional pyridylzinc reagents and palladium-catalyzed cross-coupling reactions

European Journal of Organic Chemistry

Volumn , Issue 22, 2001, Pages 4207-4212

  Alami, Mouâd ^a   Peyrat, Jean François ^a   Belachmi, Larbi ^b   Brion, Jean Daniel ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b FACULTÉ DES SCIENCES ET TECHNIQUES GUÉLIZ   (Morocco)

Author keywords

Natural products; Nitrogen heterocycles; Palladium; Zinc

Indexed keywords

2,6 DIBROMOPYRIDINE; 4 IODOBENZOIC ACID; 6 BROMO 2 PYRIDYLZINC CHLORIDE; ALKYNE DERIVATIVE; AROTINOID; ETHYL 4 [6 (2H CHROMEN 3 YL)PYRIDIN 2 YL]BENZOATE; ETHYL 4 [[6 (2H CHROMEN 3 YL)PYRIDIN 2 YL]ETHYNYL]BENZOATE; METHYL 4 [6 [(2H CHROMEN 3 YL)ETHYNYL]PYRIDIN 2 YL]BENZOATE; PALLADIUM; PYRIDINE DERIVATIVE; TRIFLUOROMETHANESULFONIC ACID; UNCLASSIFIED DRUG; ZINC DERIVATIVE;

ARTICLE; CHEMICAL BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; PHARMACOPHORE; REACTION ANALYSIS;

EID: 0035186493     PISSN: 1434193X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0690(200111)2001:22<4207::AID-EJOC4207>3.0.CO;2-3     Document Type: Article

References (48)

1. For reviews on retinoids see: [1a] M. B. Sporn, A. B. Roberts, D. S. Goodman, The Retinoids, Biology, Chemistry and Medicine, 2nd ed., Raven Press, New York, 1994.
2. [1b] J. D. Brion, in: Medicaments en relation avec les systèmes hormonaux 1995, vol. 4 du traité de Chimie Thérapeutique, AFECT eds, Tec et Doc Lavoisier, Paris, p. 745.
3. [1c] M. A. Livrea, G. Vidali, in: Retinoids from basic science to clinical applications, Birkhäuser, Basel, 1994.
4. [1d] E. E. Bittar, G. V. Sherbet, Advances in Organ Biology, vol. 3, Retinoids: Their psychological function and therapeutic potential, JAI Press Inc., 1997, p. 277.
5. R. Lotan, Biochim. Biophys. Acta 1980, 605, 33-91.
6. R. Kaplan, D. H. Russel, N. J. Lowe, J. Am. Acad. Dermatol. 1983, 8, 95-102.
7. [4a] H. Mori, T. Tanaka, Drugs of the Future 1993, 18, 737-742.
8. [4b] S. Nagpal, R. A. S. Chandraratna, Curr. Pharmac. Des. 1996, 2, 295-316.
9. [5a] J. L. Clifford, J. M. Miano, S. M. Lippman, in: Antiangiogenic Agents in Cancer Therapy (Ed.: B. A. Teicher); Humana Press Inc., Totowa, NJ; p. 335, 1999.
10. [5b] R. Pakala, C. R. Benedict, Eur. J. Pharmacology 1999, 385, 255-261.
11. [6a] J. D. Brion, G. Lebaut, G. Poissonnet, L. De Montarby, L. Belachmi, J. Bonnet, M. Sabatini, C. Tordjman, European Patent Application B.591046 (April 06, 1994); U. S. Patent A.5391569 (February 21, 1995).
12. [6b] J. D. Brion, G. Lebaut, P. Ducrey, S. Robert-Piessard, C. A. Cudennec, G. Seurre, European Patent Application B.338895 (March 23, 1990); U. S. Patent A.4975455 (December 04, 1990).
13. [6c] J. D. Brion, G. Lebaut, P. Ducrey, S. Robert-Piessard; C. A. Cudennec, G. Seurre, European Patent Application B.337885 (March 17, 1993); U. S. Patent A.4975454 (December 04, 1990).
14. [7a] K. M. Waugh, K. D. Berlin, W. T. Ford, E. M. Holt, J. P. Carrol, P. A. Schomber, M. D. Thompson, L. J. Schiff, J. Med. Chem. 1985, 28, 116-124.
15. [7b] D. M. Benbrook, M. M. Madler, L. W. Spruce, P. J. Birckbichler, E. C. Nelson, S. Subramanian, G. M. Weerasekare, J. B. Gale, M. K. Jr. Patterson, B. Wang, W. Wang, S. Lu, T. C. Rowland, P. DiSivestro, C. Lindamood III, D. L. Hill, K. D. Berlin, J. Med. Chem. 1997, 40, 3567-3583.
16. [7c] D. M. Benbrook, S. Subramanian, J. B. Gale, S. Liu, C. W. Brown, M. F. Boehm, K. D. Berlin, J. Med. Chem. 1998, 41, 3753-3757.
17. [7d] V. Vuligonda, A. M. Standeven, M. Escobar, R. A. S. Chandraratna, Bioorg. Med. Chem. Lett. 1999, 9, 743-748.
18. [7e] V. Vuligonda, R. A. S. Chandraratna, Bioorg. Med. Chem. Lett. 1999, 9, 2289-2290.
19. T. Esgleyes-Ribot, R. A. S. Chandraratna, D. Lew-Kaya, J. Sefton, M. Duvic, J. Am. Acad. Dermatol. 1994, 30, 581-590.
20. The use of 2,6-dibromopyridine as a synthetic equivalent for the synthon 9 is well documented; see: [9a] J. J. Li, G. W. Gribble (Eds.), in: Palladium in Heterocyclic Chemistry. A Guide for the Synthetic Chemist; Pergamon, Elsevier Science, Oxford, 2000.
21. [9b] V. N. Kalinin, Synthesis 1991, 413-432. For recent work see:
22. [9c] R. A. Fallahpour, Synthesis 2000, 1138-1142.
23. E. Negishi, A. O. King, N. Okukado, J. Org. Chem. 1977, 42, 1821-1823.
24. [11a] D. Cai, D. L. Hughes, T. R. Verhoeven, Tetrahedron Lett. 1996, 37, 2537-2540.
25. [11b] M. A. Peterson, J. R. Mitchell, J. Org. Chem. 1997, 62, 8237-8239 and references therein. For the preparation of 6-bromo-2-pyridylmagnesium chloride and reaction with various electrophiles see:
26. [11c] F. Trécourt, G. Breton, V. Bonnet, F. Mongin, F. Marsais, G. Quéguiner, Tetrahedron 2000, 56, 1349-1360.
27. [11d] A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2000, 39, 4414-4435.
28. For the transmetallation to the tin derivative see: M. Benaglia, S. Toyota, C. R. Woods, J. S. Siegel, Tetrahedron Lett. 1997, 38, 4737-4740.
29. 2(dppf) as a highly effective catalyst for the coupling of organozinc reagents is well known; see: [13a] T. Hayashi, M. Konishi, Y. Kobri, M. Kumada, T. Higuchi, K. Hirotsu, J. Am. Chem. Soc. 1984, 106, 158-163.
30. [13b] M. Rottländer, P. Knochel, Tetrahedron Lett. 1997, 38, 1749-1752 and references therein.
31. [14a] M. Alami, G. Cahiez, B. Castro, E. Riguet, European Patent Application 97940192.4-2103 (September 08, 1997).
32. [14b] M. Alami, G. Cahiez, B. Castro, J. R. Dormoy, E. Riguet, Patent 96 11514 (September 20, 1996).
33. [14c] E. Riguet, M. Alami, G. Cahiez, Tetrahedron Lett. 1997, 38, 4397-4400.
34. For the coupling of 12b with alkyl or aryltin reagents and borane derivatives under palladium catalysis conditions see: S. Usse, G. Guillaumet, M. C. Viaud, Tetrahedron Lett. 1997, 38, 5501-5502.
35. E. J. Corey, L. I. Wu, J. Am. Chem. Soc. 1993, 115, 9327-9328.
36. K. Sonogashira, Y. Tohda, N. Hagihara, Tetrahedron Lett. 1975, 4467-4470.
37. E. J. Corey, P. L. Fuchs, Tetrahedron Lett. 1972, 3769-3772.
38. L. René, R. Royer, Eur. J. Med. Chem. Chim. Ther. 1975, 10, 72-79.
39. P. Michel, D. Gennet, A. Rassat, Tetrahedron Lett. 1999, 40, 8575-8578.
40. For the synthesis of terminal alkyne 15b see: N. A. Bumagin, A. B. Ponomaryov, I. P. Beletskaya, Synthesis 1984, 728-729.
41. A. Torrado, B. Imperiali, J. Org. Chem. 1996, 25, 8940-8948 and references therein.
42. R. D. Coulson, Inorg. Synth. 1972, 13, 121-124.
43. H. Itatani, J. C. Bailer, J. Am. Oil. Chem. Soc. 1967, 44, 147-149.
44. R. Takeuchi, N. Ishii, M. Sugiura, N. Sato, J. Org. Chem. 1992, 57, 4189-4194.
45. M. Pigini, L. Brasili, A. Cassinelli, D. Giardina, U. Gulini, Eur. J. Med. Chem. Ther. 1987, 22, 273-276.
46. [27a] G. Ariamala, K. K. Balasubramanian, Tetrahedron 1989, 45, 3769-3774.
47. [27b] C. Walling, G. M. El-Taliawi, C. Zhao, J. Org. Chem. 1983, 48, 4914-4917.
48. B. Gopalan, K. Rajagopalan, S. Swaminathan, Synthesis 1976, 752-754.